MANDATO, Claudia
 Distribuzione geografica
Continente #
AS - Asia 5.272
NA - Nord America 4.504
EU - Europa 1.421
SA - Sud America 548
AF - Africa 83
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 1
Totale 11.834
Nazione #
US - Stati Uniti d'America 4.413
HK - Hong Kong 2.908
SG - Singapore 1.145
BR - Brasile 422
CN - Cina 420
IT - Italia 368
VN - Vietnam 363
RU - Federazione Russa 245
UA - Ucraina 165
FR - Francia 126
DE - Germania 119
IE - Irlanda 110
IN - India 73
KR - Corea 60
TR - Turchia 58
GB - Regno Unito 52
FI - Finlandia 48
AR - Argentina 46
SE - Svezia 46
MX - Messico 42
IL - Israele 41
BD - Bangladesh 34
CA - Canada 32
NL - Olanda 32
JP - Giappone 30
AT - Austria 29
IQ - Iraq 27
EC - Ecuador 23
PL - Polonia 21
ID - Indonesia 19
ZA - Sudafrica 19
PK - Pakistan 16
TN - Tunisia 16
VE - Venezuela 16
CO - Colombia 14
ES - Italia 13
SA - Arabia Saudita 11
CZ - Repubblica Ceca 10
PH - Filippine 10
ET - Etiopia 9
MA - Marocco 9
UZ - Uzbekistan 9
PE - Perù 8
DZ - Algeria 7
KE - Kenya 7
BY - Bielorussia 6
CL - Cile 6
OM - Oman 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
EU - Europa 5
JO - Giordania 5
LB - Libano 5
BE - Belgio 4
BO - Bolivia 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
AZ - Azerbaigian 3
GR - Grecia 3
HN - Honduras 3
KW - Kuwait 3
LT - Lituania 3
SV - El Salvador 3
AL - Albania 2
BG - Bulgaria 2
MD - Moldavia 2
MU - Mauritius 2
PS - Palestinian Territory 2
SN - Senegal 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
GF - Guiana Francese 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
ML - Mali 1
MN - Mongolia 1
MW - Malawi 1
NG - Nigeria 1
Totale 11.826
Città #
Hong Kong 2.895
Singapore 607
San Jose 594
Ann Arbor 567
Dallas 327
Woodbridge 317
Ashburn 312
Chandler 288
Princeton 222
Jacksonville 191
Wilmington 167
Houston 152
Council Bluffs 144
Lauterbourg 114
Dublin 102
The Dalles 100
Ho Chi Minh City 97
Naples 93
Beijing 86
Dong Ket 76
Hanoi 66
Moscow 51
Los Angeles 50
New York 43
Nanjing 41
Izmir 40
Dearborn 39
Andover 35
Boardman 35
Pellezzano 33
Santa Clara 32
São Paulo 31
Salerno 30
Tokyo 28
Washington 26
Amsterdam 23
Mestre 23
Brooklyn 22
Atlanta 20
Frankfurt am Main 20
Vienna 20
Denver 19
Munich 19
Orem 19
Warsaw 19
Chicago 18
Nuremberg 18
Stockholm 18
Düsseldorf 16
Shenyang 16
Chennai 15
San Francisco 15
Seattle 15
London 14
Baghdad 13
Norwalk 13
Pune 13
Rome 13
Da Nang 12
Fairfield 12
Haiphong 12
Johannesburg 12
Montreal 12
Quito 12
Rio de Janeiro 11
Seoul 11
West Jordan 11
Brno 10
Caracas 10
Hebei 10
Jiaxing 10
Mexico City 10
Tianjin 10
Ankara 9
Buenos Aires 9
Columbus 9
Helsinki 9
Biên Hòa 8
Curitiba 8
Nanchang 8
Phoenix 8
Poplar 8
San Diego 8
Tashkent 8
Addis Ababa 7
Belo Horizonte 7
Guayaquil 7
Tunis 7
Boston 6
Brasília 6
Charlotte 6
Jeddah 6
Lappeenranta 6
Manaus 6
Manchester 6
Arba 5
Cairo 5
Cuiabá 5
Des Moines 5
Eboli 5
Totale 8.784
Nome #
Hepatitis B virus and the paediatric liver: waiting for news on the horizon 741
Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other 361
Liver and Pancreatic Involvement in Children with Multisystem Inflammatory Syndrome Related to SARS-CoV-2: A Monocentric Study 356
Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement 338
Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment. 302
Thyroid dysfunction and its role as a risk factor for non-alcoholic fatty liver disease: What's new 254
A systematic review of pediatrics NAFLD therapy: year 2012 236
Metabolomic salivary signature of pediatric obesity related liver disease and metabolic syndrome 230
Refractory primary sclerosing cholangitis becoming responsive after sulphasalazine treatment of an underlying silent colitis 204
Humanization interventions in general pediatric wards: a systematic review 192
Management of adults with paediatric-onset chronic liver disease: Strategic issues for transition care 183
A NEW POSSIBLE THERAPEUTIC STRATEGY IN OBESITYRELATED LIVER DISEASE: PRELIMINARY DATA WITH LACTOBACILLUS RHAMNOSUS STRAIN GG 178
Hepatic Presentation of Late-Onset Multiple Acyl-CoA Dehydrogenase Deficiency (MADD): Case Report and Systematic Review 172
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 166
Atypical celiac disease presenting as obesity-related liver dysfunction. 165
Autoimmune manifestations in pediatric liver transplantation recipients 154
Antioxidant vitamin E for the treatment of obesità related liver dysfunction in children with poor compliance to hypocaloric diets 154
Textbook of liver transplatation. Transition to Adult Care: Adolescents Care 150
Autoantibodies against CYP-2C19: A Novel Serum Marker in Pediatric De Novo Autoimmune Hepatitis? 146
Probiotics in the treatment of Non Alcoholic Fatty Liver Disease: Further evidence in obese children 140
Autoimmune manifestations in children transplanted for non-autoimmune liver diseases 135
LACTOBACILLUS RHAMNOSUS STRAIN GG DESERVES CONSIDERATION AS A THERAPEUTIC TOOL IN OBESITY-RELATED LIVER DISEASE 135
Metabolic, hormonal, oxidative, and inflammatory factors in pediatricobesity-related liver disease 133
Analgesic effects of breast- and formula feeding during routine childhood immunizations up to 1 year of age 133
Cytochrome 2C19: a New Hepatic Target of Immune Reactions After Orthopic Liver Transplantation. 130
Gut-liver axis and probiotics: Their role in non-alcoholic fatty liver disease 126
Novel congenital disorders of glycosylation may underlie cryptogenic liver disease in children. 122
Probiotics: a possible role in treatment of adult and pediatric non alcoholic fatty liver disease 122
Insulin sensitivity and iron metabolism in pediatric obesity related liver disease. 120
Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions 119
Cryptogenic liver disease in four children: a novel congenital disorder of glycosylation 118
Chronic liver disease in two children exposed to moderately high levels of copper in drinking water. 118
More on current evidences on probiotics as a novel treatment for non-alcoholic Fatty liver disease 118
Interplay between metabolic, oxidative, inflammatory and hormonal factors in pediatric obesity related liver disease. 117
Congenital defects of glycosylation may underlie cryptogenic hepatopathy in asymptomatic children 116
Frequent persistence of hepatic abnormalities in children with hereditary fructose intolerance (HFI) is not correlated to specific gene mutations. 115
A ZFYVE19 gene mutation associated with neonatal cholestasis and cilia dysfunction: case report with a novel pathogenic variant 115
Oral vitamin E has beneficial effects on liver disease of obese children unable to loose weight 113
Pediatric vs. adult NAFLD to MAFLD transition: a welcome but tangled path 113
Per-rectal portal scintigraphy is complementary to ultrasonography and endoscopy in the assessment of portal hypertension in children with chronic cholestasis 111
Chronic ingestion of moderately high copper may cause cryptogenic mild liver disease 108
Non-cirrhotic chronic liver disease in three italian children exposed to moderately high copper intakes 106
Humanization of pediatric care in the world: focus and review of existing models and measurement tools. 103
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy 103
Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature 101
Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. 98
Human Parvovirus B19 Infection in liver transplanted children with chronic hematologic disorders. 97
More on vitamin E therapy 96
Global multi-stakeholder endorsement of the MAFLD definition 89
Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review 86
Outbreak of paediatric myocarditis associated with parvovirus B19 infection in Italy, January to October 2024 83
Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation 80
Liver Involvement in Congenital Disorders of Glycosylation: A Systematic Review 77
Crohn-Like Colitis in a Young Boy with Hirschsprung Disease 75
Case report: Reversible Fanconi syndrome due to vitamin D deficiency in a patient with epilepsy harbouring a pathogenic variant in the SLC34A1 gene 74
Case report: Unusual and extremely severe lipoprotein X-mediated hypercholesterolemia in extrahepatic pediatric cholestasis 73
Nutrition and Liver Disease 71
Genotypes and different clinical variants between children and adults in progressive familial intrahepatic cholestasis: a state-of-the-art review 69
Multiple Sclerosis-Related Dietary and Nutritional Issues: An Updated Scoping Review with a Focus on Pediatrics 69
Pediatric Fatty Liver and Obesity: Not Always Justa Matter of Non-Alcoholic Fatty Liver Disease 69
Multisystem inflammatory syndrome in children. An emerging clinical challenge for pediatric surgeons in the COVID 19 era 69
Ittero e feci ipocoliche: allarme atresia delle vie biliari 67
Drug dosing in children with obesity: a narrative updated review 66
Diagnostic Approach to Acute Liver Failure in Children: A Position Paper by the SIGENP Liver Disease Working Group 66
Malnutrition in pediatric chronic cholestatic disease: An up-to-date overview 65
Real-word experience with Odevixibat in children with Progressive Familial Intrahepatic Cholestasis 63
Clinical heterogeneity of Kabuki syndrome in a cohort of Italian patients and review of the literature 63
Bassa statura non sindromica e ritardo puberale: non solo ritardo costituzionale di crescita e pubertà 62
Monkeypox Infection 2022: An Updated Narrative Review Focusing on the Neonatal and Pediatric Population 62
Laryngeal Mask for Minimally-Invasive Surfactant Administration: A Narrative Review 61
Cholestatic jaundice in infancy: Struggling with many old and new phenotypes 61
ALAGILLE SYNDROME: IS IT ALWAYS CHOLESTASIS? 60
Genetics, epigenetics and transgenerational transmission of obesity in children 59
The gut-liver axis as a target of liver disease management 58
Diagnostic approach to neonatal and infantile cholestasis: A position paper by the SIGENP liver disease working group 58
Reasons why treatment of metabolic dysfunction‐associated steatotic liver disease may benefit from targeting the gut–liver axis as well 57
Systemic Cat-Scratch Disease: a "Troublesome" Diagnosis 54
Pulmonary lipid modulation: A possible therapeutic target for SARS-CoV-2 infection 54
Consumptive Hypothyroidism due to Hepatic Hemangiomas: A Case Series and Review of the Literature 53
Frailty in children with chronic liver disease: Growing evidence for an underexplored topic 52
Celiac Disease on the Bed-Side: Embedding Case Finding and Screening in Hospitalized Children 51
A persistent fever associated with elevated inflammatory indices and ultrasound lesions of liver and spleen 51
Acute hepatitis of unknown origin in children: Should we move the discussion from a purely infectious origin also to other plausible causes? 51
Letter to the editor in response to distinguishing autoimmune hepatitis from steatohepatitis in adolescents with obesity and positive screening alanine aminotransferase 50
Bronchiolitis: Compliance with guidelines 50
An odd septic arthritis of the hip 50
Primary and Secondary Prophylaxis of Gastrointestinal Bleeding in Children with Portal Hypertension: A Multicenter National Study by SIGENP 50
Vitamin D Levels in the Pre- and Post-COVID-19 Pandemic Periods and Related Confinement at Pediatric Age 48
Case Report: Add-on treatment with odevixibat in a new subtype of progressive familial intrahepatic cholestasis broadens the therapeutic horizon of genetic cholestasis 47
An almost accidentally diagnosis 47
Evaluation of non organ specific autoantibodies in children transplanted for non-autoimmune liver diseases 46
Letter to the Editor in response to: “ZFYVE19 gene mutation: A novel variant of progressive familial intrahepatic cholestasis” 46
Perceptions and Expectations of Youth Regarding the Respect for Their Rights in the Hospital 45
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome 44
Emerging, re‐emerging and/or atypically behaving infectious diseases 43
Thrombotic Features as the Primary Cause of SARS-CoV-2 Related Acute Abdomen in Children 41
Isolated aspartate aminotransferase elevation: Is it liver disease or what else? 41
Nutritional therapy in liver transplantation 41
The C677T mutation of the 5,1O-methylenetetrahydrofolate reductase gene is a moderate risk factor for spina bifida in Italy 40
The complexity of diagnosing a drug reaction syndrome in the child|La complessità della diagnosi di una sindrome da reazione a farmaco nel bambino 40
Totale 11.110
Categoria #
all - tutte 38.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021138 0 0 0 0 0 0 0 0 0 7 44 87
2021/2022360 5 0 0 3 6 2 1 10 52 39 51 191
2022/2023721 70 51 54 83 78 158 1 56 120 4 35 11
2023/2024533 29 48 43 25 32 89 41 24 14 43 24 121
2024/20251.193 21 22 19 54 42 190 185 100 184 101 175 100
2025/20267.057 375 1.840 1.514 322 658 282 987 241 329 509 0 0
Totale 12.028